Terri Gaskell | CTO, Rinri Therapeutics
Restoring Hearing. Redefining Possibility.
In this episode, I speak with Terri Gaskell, Chief Technology Officer at Rinri Therapeutics, about the revolutionary work her team is doing to treat sensorineural hearing loss through stem cell therapy.
Terri shares her remarkable journey from academia to biotech, the real-world hurdles of early-stage leadership, and the power of staying grounded (even when things get weird, wild, or wonderfully promising).
We talk science, strategy, identity, and authenticity — all wrapped up in a clinical trial story that just might restore hearing for those who’ve lost it.
🎙️ This episode of She Leads Biotech is proudly sponsored by Phacilitate & Women in Advanced Therapies (WIAT).
📌 Chapters / Timestamps:
00:00 – Meet Terri Gaskell & the Rinri mission
03:05 – The science behind restoring hearing via stem cells
07:20 – From university spinout to clinical trials: how it all began
11:40 – Navigating burnout & building balanced leadership
14:30 – Why authenticity matters more than ever in biotech
17:25 – Terri’s Women in Advanced Therapies experience
19:40 – The highs, lows, and marigolds of team management
22:55 – How academia prepared (and didn’t prepare) her for biotech
26:15 – Advice for new biotech leaders: confidence vs competence
29:30 – Rinri’s clinical pipeline and what’s next
33:00 – Final reflections on purpose, progress, and patient impact
#SheLeadsBiotech #TerriGaskell #RinriTherapeutics #HearingLoss #CellTherapy #BiotechLeadership #WomenInSTEM #RegenerativeMedicine #CNAInternationalUSA #SharronCoxStudio #WIAT #Phacilitate #LifeSciences
